This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Pharmaceutical Drug Delivery Market

Market Insights on Pharmaceutical Drug Delivery covering sales outlook, demand forecast & up-to-date key trends

Pharmaceutical Drug Delivery Market Analysis by Facility of Use (Hospitals, Ambulatory Surgery Centers/Clinics, Home Care Settings, Diagnostic Centers, & Other Facilities of Use), Application, Route of Administration, & Region - Forecast to 2022-2032

Pharmaceutical Drug Delivery Market Outlook 2022-2032

[321 Pages Report] During the assessment period, the global Pharmaceutical Drug Delivery Market is expected to increase at a robust CAGR of 6%, from US$ 1600 Bn in 2021 to US$ 3000 Bn by 2032.

"The growing incidence of infectious diseases globally, expanding R&D expenditure for innovative medicines, and rising FDA approvals all contribute to the expansion of this market category."

Companies like Evonik (Germany) have made substantial pharmaceutical drug delivery systems investments. For example, it acquired SurModics, specialising in controlled-release parenteral applications. To better compete in this industry, Evonik purchased complementary technologies, including Boehringer Ingelheim's RESOMER platform. 

The company also announced WuXi Vaccines in 2019 as a joint venture with Shanghai Hile Bio-Technology Co. WuXi Vaccines will develop specialised pharmaceutical drug delivery systems for the global market. A new class of medicines has emerged in the biopharmaceutical sector, with tremendous potential in cancer, diabetes, and other diseases.

Attributes

Details

Pharmaceutical Drug Delivery Market CAGR (2022 – 2032)

6%

Pharmaceutical Drug Delivery Market

US$ 2200 Bn

Pharmaceutical Drug Delivery Market Attraction

Investments in R&D activities to create opportunities

Customize this Report

Let us know your requirement to get
100% FREE customization

How Severe is the COVID-19 Impact on Pharmaceutical Drug Delivery Market?

In the pharmaceutical drug market, the impact of fear of getting infected by coronavirus was more profound than the actual cases of Covid-19 during the initial days of the pandemic. Due to widespread panic among patients suffering from immunodeficiency diseases, multivitamins and antivirals were the main pharmaceuticals high for sale.

However, the pharmaceutical manufacturers experienced a significant drop in sales of drugs for more serious diseases as all the resources of the healthcare sector got focused on dealing with Covid-19 cases.

After some months, when it was realized that some other diseases could escalate the effects of the Covid-19 outcome, pharmaceutical products in all categories revived to some extent. The pandemic has immensely benefited the pharmaceutical companies as there has been an improvement in general consciousness to take proper care of health-related issues.

What are the Key Pharmaceutical Drug Delivery Market Dynamics?

"Increasing investments by major market players in pharmaceutical drug delivery systems research and development is driving market expansion."

Firms such as Evonik (Germany) have implemented several strategic initiatives to recognize the potential for biologics production. The firm expanded its manufacturing capacity by purchasing SurModics, a company specializing in controlled-release parenteral applications. 

Additionally, Evonik enhanced its competence in this industry by acquiring complementary technologies, such as Boehringer Ingelheim's RESOMER platform. Similarly, WuXi Biologics launched WuXi Vaccines in 2019, a joint venture with Shanghai Hile Bio-Technology Co., Ltd. 

The firms formed a strategic alliance under which WuXi Vaccines would establish a specialized facility and offer a commercial product to the worldwide market. The pharmaceutical drug delivery system has seen the introduction of a new class of therapies with tremendous potential for novel cancer, diabetes, and other disease treatments.

What are the Constraints of the Global Market Study on Pharmaceutical Drug Delivery?

Needlestick injuries are one of the greatest threats to an individual's health and safety. Each year, around 600,000 to 800,000 needlestick injuries are reported in the United States, according to PharmaJet. According to OSHA, about 5.6 million employees in the United States of America are at risk of contracting blood-borne diseases as a consequence of needlestick injuries in pharmaceutical drug delivery systems.

Additionally, the CDC estimates that each year manufacturers in the United States struggle with wrong practices of needlestick disposal issues. An average of 385,000 needlestick injuries occur in hospital settings. Similarly, each year in Europe, nearly 1 million needlestick injuries are reported (Source: Becton, Dickinson and Company).

Manufacturers and pharma delivery companies are struggling in the market due to these major constrain. Every manufacturer is looking towards auto disposable of these needlesticks to prevent reuse. 

What are the Pharmaceutical Drug Delivery Market Key Trends & Opportunities?

Self-administration and home care are anticipated to present major potential prospects for pharmaceutical drug delivery systems. This is mostly attributable to the growing geriatric population since older folks provide a sizable client base for home care drug delivery devices

This issue also contributes to the increased need for application-specific injectable, inhalation, topical, and transdermal medication treatments that address the demands of caregivers and patients.

How is Pharmaceutical Drug Delivery Market Growth being Seized by Certain Challenges?

Governments in rich and developing nations alike are advocating cost-cutting initiatives such as lowering medication reimbursement rates and boosting the use of generics. Pharmaceutical drug delivery systems worldwide are under enormous cost-cutting pressure from government agencies, insurers, and patients. 

This lower pricing pressure results in increased medication acceptance in emerging economies, where there is a considerable need for low-cost treatments. This, however, has a detrimental effect on the profitability of a number of pharmaceutical drug delivery systems.

This trend is expected to continue in the coming years as insurers, pharmacy benefit managers (PBMs), and public and private payers continue to press for better pharmaceutical dosage forms and drug delivery systems in response to concerns about covering more new medicines to treat prevalent conditions such as high cholesterol and diabetes.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Comparative View of Adjacent Pharmaceutical Drug Delivery Market

 

Pharmaceutical Drug Delivery Market:

Attributes

Pharmaceutical Drug Delivery Market

CAGR (2022 - 2032)

6%

Market Value (2026)

US$ 2200 Bn

Growth Factor

Improvement in drug efficacy to improve growth rate.

Opportunity

High investments in R&D activities to offer opportunities.

Key Trends

APAC is the key region to stay invested in.

Drug Discovery Services Market:

Attributes

Drug Discovery Services Market

CAGR (2022 - 2032)

14.5%

Market Value (2026)

US$ 32 Bn

Growth Factor

Readiness to outsource drug discovery services to support market growth.

Opportunity

Emerging Asia Pacific market hold high attraction quotient.

Key Trends

Cross-industry collaboration to improve drug efficiency and boost adoption.

Drug Testing Market:

Attributes

Drug Testing Market

CAGR (2022 - 2032)

5%

Market Value (2026)

US$ 27.5 Bn

Growth Factor

Government mandates for monitoring and combating substance abuse to augment adoption.

Opportunity

Investment in consumables for the development of advanced products to offer lucrative opportunities.

Key Trends

Demand for innovative testing solutions for opioid to remain high.

Demand for user-friendly devices with smart, large-volume drug dosing and fewer side effects will boost the pharmaceutical drug delivery market growth.

The growing popularity and adoption of needle-free injectors, self-injectors, auto-injectors, and pen-injectors have allowed patients to conveniently administer drugs from the comfort of their own homes, majorly contributing to the pharmaceutical drug delivery adoption trends

Furthermore, rising investments by top pharmaceutical drug delivery industry players in research and development regarding the delivery of pharmaceuticals and clinical trials are scaling up their pharmaceutical drug delivery market share

A major emerging trend in the pharmaceutical drug delivery market is the proliferation of technologies that have made it possible to administer drugs easily and conveniently through various roots and surged the demand for pharmaceutical drug delivery solutions.

Developing economies with high growth potential are expected to provide lucrative pharmaceutical drug delivery market opportunities.

The rapidly expanding biopharmaceuticals industry, which is one of the pharmaceutical drug delivery market trends, has aided in developing several novel pharmaceutical drugs that can effectively treat a variety of non-communicable diseases and novel drug delivery systems for pharmaceuticals.

The penetration of healthcare start-ups will facilitate innovation in both developing and developed countries, thereby augmenting the pharmaceutical drug delivery market size.

Higher investments in nanotechnology-based devices, combined with a shift toward home-based care, are all expected to foster the adoption of pharmaceutical drug delivery systems.

One of the crucial recent developments in the pharmaceutical drug delivery market is the shift of the focus from delivering the right molecule and deciding the delivery mode later to deciding drug/pharmaceutical delivery earlier by pharma delivery companies.

This has given rise to the pharmaceutical industry's digitalization trends, positively influencing future trends of the pharmaceutical drug delivery market

Apps, wellness, education, and adherence are examples of how the digital experience is being applied to the medication delivery space in the pharmaceutical drug delivery market.

The digital aspect of the delivery of pharmaceuticals benefits patients by ensuring that they receive the appropriate therapeutic dose for their diagnosed condition, which also spikes the sales of pharmaceutical drug delivery devices.

How is the Pharmaceutical Drug Delivery Market Segmented?

Until 2020, the retail pharmacies/drug stores segment accounted for nearly 62% of the total transaction of pharmaceutical pills around the world. However, after the growing trend of digital methods, e-commerce websites have now emerged as the popular distribution channel for pharmaceutical products.

What are the Different Segments in the Pharmaceutical Drug Delivery Market based on Routes of Administration?

Pharmaceutical drugs have been developed to be placed inside the body of patients suffering from several illnesses or supplement the body with essential chemical formulas required by the body. Owing to the ease of intake Oral drug delivery segment is the most preferred method of administration, having the largest consumer base. Injectable drug delivery is also commonly used by medical professionals for a large group of pharmaceutical medicines. Both these segments are the main product segments delivered by all pharmaceutical companies.

Ocular and pulmonary drug delivery segments are also important to segment for the pharmaceutical market products. Other than that, nasal drug delivery, transmucosal drug delivery and implantable drug delivery are the emerging segments for drug manufacturing with the development of new treatment methods.

What are the Major Applications of Pharmaceutical Drug Delivery Systems?

The global pharmaceutical drug delivery market can be categorized based on different applications of its drug. Due to the use of many chemical drugs to treat widespread Infectious diseases around the world, this segment is the major contributor to the revenue generated by biotech and pharmaceutical companies supplying resources for healthcare sectors.

Also, there have been increasing incidences of respiratory diseases, autoimmune diseases, and central nervous system disorders in recent times. Advancement in medical sciences has opened up new avenues for the development of new drugs to control such diseases that will boost the business of small generic pharmaceutical companies.

Which are the Leading Facilities Driving the Demand for Pharmaceutical Drug Delivery Systems?

Hospital and diagnostic centres are the prominent facilities being the major consumers of the pharmaceutical drug market. There has been a sharp rise in demand for pharmaceutical trade by online platforms for providing drugs for homecare facilities in recent times.

Ambulatory Surgery centres or local clinics are some of the new applications of the pharmaceutical drug market experiencing rapid growth due to rising health issues among the population. Therefore, this segment is predicted to hold a higher growth potential during the forecast period, being increasingly targeted by start-up pharmaceutical companies.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Why is North America a Dominant Pharmaceutical Drug Delivery Market?

Despite more concentration of population and incidence of illness and diseases in the Asia Pacific and Africa regions, North America is the dominant region for the global pharmaceutical drug market.

Owing to the robust healthcare infrastructure and awareness to maintain a healthy lifestyle, the countries in North America together contributed nearly 44% of total revenue generated by pharmaceutical pill consumption by 2020. Also, the rising cases of chronic diseases and innovations in drug delivery technologies are sighted as some of the reasons for prominent players in the region.

The Asia Pacific comes second in terms of market size because third-party pharmaceutical manufacturing companies are present in India and China. By the continuous effort of international and non-governmental organizations, Latin America and Middle East African countries are also gaining momentum in healthcare services.

Due to increasing government support, there has been a significant improvement in the pharmaceutical drug prices favouring the pharmaceutical drug market by a CAGR of 9% and 8%, respectively, during the forecast period.

Who are the Prominent Players in the Pharmaceutical Drug Delivery Market?

To increase the speed of market penetration of different products, top pharmaceutical companies are increasingly using biomarkers to develop drugs. Companies are also significantly investing in developing technologies for more effective antibody-drug conjugates (ADCs), fusion proteins, and cell and gene therapy.

Some of the pharmaceutical manufacturing and marketing industries that have established themselves as the top players of the global market are Novartis International AG, F.Hoffmann-La Roche AG, Pfizer Inc, Becton Dickinson & Company, GlaxoSmithKline PLC, Merck & Co Inc, Sanofi S.A., Bayer medicine products AG, 3M.

 Recent Developments in the Pharmaceutical Drug Delivery Market:

  • To expand its business activities in an emerging field of synthetic lethality associated with oncology, GlaxoSmithKline PLC signed a partnership with IDEAYA in Nov 2020. They plan to complete the clinical trials of its programs MAT2A, Pol Theta, and Werner Helicasa by the end of 2023.
  • For the patients suffering from braf v600e-mutant metastatic colorectal cancer (CRC) and who have undergone prior therapy, Pfizer Inc. Company has developed a combination of BRAFTOVI (encorafenib) plus cetuximab that received approval from the Food & Drug Administration (FDA) back in December 2020.
  • Johnson & Johnson has also received the approval from Food & Drug Administration (FDA) for its subcutaneous formulation product named DARZALEX (daratumumab) in July 2021, which can help reduce the treatment time for several indications of myeloma.
  • Samsung Biologics Co., a subsidiary of the giant South Korean technology company, has invested around US$ 740 Mn for the development and production of next-generation biologics.

Key Segments

By Route of Administration:

  • Oral Drug Delivery
  • Injectable Drug Delivery
  • Topical Drug Delivery
  • Ocular Drug Delivery
  • Pulmonary Drug Delivery
  • Nasal Drug Delivery
  • Transmucosal Drug Delivery
  • Implantable Drug Delivery

By Application:

  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Diseases
  • Central Nervous System Disorders
  • Autoimmune Diseases
  • Other Applications

By Facility of Use:

  • Hospitals
  • Ambulatory Surgery Centers/Clinics
  • Home Care Settings
  • Diagnostic Centers
  • Other Facilities of Use

By Region:

  • North America
  • Latin America
  • Europe
  • Europe
  • Asia Pacific
  • Middle East and Africa (MEA)

Frequently Asked Questions

The pharmaceutical drug delivery systems market is expected to increase at a robust 6% CAGR during the projected period.

The global pharmaceutical delivery market was worth US$ 1600 Bn in 2021.

By 2032, the pharmaceutical drug delivery systems industry is anticipated to be worth roughly US$ 3000 Bn.

In the North American Region, the market owing to the rising prevalence of chronic diseases, such as cancer in pharmaceutical drug delivery systems, is propelling.

By 2026, the worldwide pharmaceutical drug delivery market is expected to be worth approximately US$ 2200 Bn.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook 

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Fact.MR Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy 

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

    3.1. Risk Assessment 

        3.1.1. COVID-19 Crisis and Impact on Demand

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis 

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background

    4.1. Market, by Key Countries

    4.2. Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast 

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario 

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors 

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking 

6. Global Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Route of Administration

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2015-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2022-2032

        8.3.1. Oral Drug Delivery

            8.3.1.1. Solid Oral Drugs

                8.3.1.1.1. Tablets

                8.3.1.1.2. Capsules

                8.3.1.1.3. Powders

                8.3.1.1.4. Pills

            8.3.1.2. Liquid Oral Drugs

                8.3.1.2.1. Syrups

                8.3.1.2.2. Solutions

            8.3.1.3. Semi Solid Oral Drugs

                8.3.1.3.1. Gels

                8.3.1.3.2. Emulsions

                8.3.1.3.3. Elixirs

        8.3.2. Injectable Drug Delivery

            8.3.2.1. Conventional Injection Devices

                8.3.2.1.1. By Material

                    8.3.2.1.1.1. Glass Syringes

                    8.3.2.1.1.2. Plastic Syringes

                8.3.2.1.2. By Product

                    8.3.2.1.2.1. Fillable syringes

                    8.3.2.1.2.2. Prefilled syringes

                8.3.2.1.3. By Usability

                    8.3.2.1.3.1. Reusable syringes

                    8.3.2.1.3.2. Disposable syringes

            8.3.2.2. Self-Injection Devices

                8.3.2.2.1. Needle-free Injectors

                8.3.2.2.2. Autoinjectors

                8.3.2.2.3. Pen Injectors

                8.3.2.2.4. Wearable Injectors

            8.3.2.3. Other Injector Devices

        8.3.3. Topical Drug Delivery

            8.3.3.1. Liquid Formulations

                8.3.3.1.1. Solutions

                8.3.3.1.2. Suspensions

            8.3.3.2. Semi Solid Formulations

                8.3.3.2.1. Creams

                8.3.3.2.2. Gels

                8.3.3.2.3. Ointments

                8.3.3.2.4. Pastes

                8.3.3.2.5. Lotions

            8.3.3.3. Solid Formulations

                8.3.3.3.1. Suppositories

                8.3.3.3.2. Powders

            8.3.3.4. Transdermal Products

                8.3.3.4.1. Transdermal Patches

                8.3.3.4.2. Transdermal Gels

        8.3.4. Ocular Drug Delivery

            8.3.4.1. Liquid Formulations

                8.3.4.1.1. Eye Drops

                8.3.4.1.2. Liquid Sprays

            8.3.4.2. Semi Solid Formulations

                8.3.4.2.1. Gels

                8.3.4.2.2. Eye Ointments

            8.3.4.3. Ocular Devices

                8.3.4.3.1. Drug-coated Contact Lenses

                8.3.4.3.2. Ocular Inserts

        8.3.5. Pulmonary Drug Delivery

            8.3.5.1. Metered-Dose Inhalers

            8.3.5.2. Dry Powder Inhalers

            8.3.5.3. Nebulizers

                8.3.5.3.1. Jet Nebulizers

                8.3.5.3.2. Ultrasonic Nebulizers

                8.3.5.3.3. Soft Mist Nebulizers

        8.3.6. Nasal Drug Delivery

            8.3.6.1. Nasal Drops

            8.3.6.2. Nasal Sprays

            8.3.6.3. Nasal Powders

            8.3.6.4. Nasal Gels

        8.3.7. Transmucosal Drug Delivery

            8.3.7.1. Oral Formulations

                8.3.7.1.1. Buccal Drug Delivery

                8.3.7.1.2. Sublingual Drug Delivery

            8.3.7.2. Other Transmucosal Drug Delivery Technologies

                8.3.7.2.1. Rectal Transmucosal Drug Delivery

                8.3.7.2.2. Vaginal Transmucosal Drug Delivery

        8.3.8. Implantable Drug Delivery

            8.3.8.1. Active Implantable Drug Delivery

            8.3.8.2. Passive Implantable Drug Delivery

    8.4. Market Attractiveness Analysis By Route of Administration

9. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Application

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Application, 2015-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2032

        9.3.1. Infectious Diseases

        9.3.2. Cancer

        9.3.3. Cardiovascular Diseases

        9.3.4. Diabetes

        9.3.5. Respiratory Diseases

        9.3.6. Central Nervous System Disorders

        9.3.7. Autoimmune Diseases

        9.3.8. Other Applications

    9.4. Market Attractiveness Analysis By Application

10. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Facility of Use

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Facility of Use, 2015-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Facility of Use, 2022-2032

        10.3.1. Hospitals

        10.3.2. Ambulatory Surgery Centers/Clinics

        10.3.3. Home Care Settings

        10.3.4. Diagnostic Centers

        10.3.5. Other Facilities of Use

    10.4. Market Attractiveness Analysis By Facility of Use

11. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

    11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. Asia Pacific 

        11.3.5. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Market Analysis 2015-2021 and Forecast 2022-2032

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        12.4.1. By Country

            12.4.1.1. U.S.

            12.4.1.2. Canada

            12.4.1.3. Rest of North America

        12.4.2. By Route of Administration

        12.4.3. By Facility of Use

        12.4.4. By Application

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Route of Administration

        12.5.3. By Facility of Use

        12.5.4. By Application

13. Latin America Market Analysis 2015-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. Brazil

            13.4.1.2. Mexico

            13.4.1.3. Rest of Latin America

        13.4.2. By Route of Administration

        13.4.3. By Facility of Use

        13.4.4. By Application

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Route of Administration

        13.5.3. By Facility of Use

        13.5.4. By Application

14. Europe Market Analysis 2015-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. Germany

            14.4.1.2. France

            14.4.1.3. U.K.

            14.4.1.4. Italy

            14.4.1.5. Benelux

            14.4.1.6. Nordic Countries

            14.4.1.7. Rest of Europe

        14.4.2. By Route of Administration

        14.4.3. By Facility of Use

        14.4.4. By Application

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Route of Administration

        14.5.3. By Facility of Use

        14.5.4. By Application

15. Asia Pacific Market Analysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        15.4.1. By Country

            15.4.1.1. China

            15.4.1.2. Japan

            15.4.1.3. South Korea

            15.4.1.4. Rest of Asia Pacific

        15.4.2. By Route of Administration

        15.4.3. By Facility of Use

        15.4.4. By Application

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Route of Administration

        15.5.3. By Facility of Use

        15.5.4. By Application

16. Middle East and Africa Market Analysis 2015-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        16.4.1. By Country

            16.4.1.1. GCC Countries

            16.4.1.2. South Africa

            16.4.1.3. Turkey

            16.4.1.4. Rest of Middle East and Africa

        16.4.2. By Route of Administration

        16.4.3. By Facility of Use

        16.4.4. By Application

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Route of Administration

        16.5.3. By Facility of Use

        16.5.4. By Application

17. Key Countries Market Analysis 2015-2021 and Forecast 2022-2032

    17.1. Introduction

        17.1.1. Market Value Proportion Analysis, By Key Countries

        17.1.2. Global Vs. Country Growth Comparison

    17.2. US Market Analysis

        17.2.1. Value Proportion Analysis by Market Taxonomy

        17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.2.2.1. By Route of Administration

            17.2.2.2. By Facility of Use

            17.2.2.3. By Application

    17.3. Canada Market Analysis

        17.3.1. Value Proportion Analysis by Market Taxonomy

        17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.3.2.1. By Route of Administration

            17.3.2.2. By Facility of Use

            17.3.2.3. By Application

    17.4. Mexico Market Analysis

        17.4.1. Value Proportion Analysis by Market Taxonomy

        17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.4.2.1. By Route of Administration

            17.4.2.2. By Facility of Use

            17.4.2.3. By Application

    17.5. Brazil Market Analysis

        17.5.1. Value Proportion Analysis by Market Taxonomy

        17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.5.2.1. By Route of Administration

            17.5.2.2. By Facility of Use

            17.5.2.3. By Application

    17.6. Germany Market Analysis

        17.6.1. Value Proportion Analysis by Market Taxonomy

        17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.6.2.1. By Route of Administration

            17.6.2.2. By Facility of Use

            17.6.2.3. By Application

    17.7. France Market Analysis

        17.7.1. Value Proportion Analysis by Market Taxonomy

        17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.7.2.1. By Route of Administration

            17.7.2.2. By Facility of Use

            17.7.2.3. By Application

    17.8. Italy Market Analysis

        17.8.1. Value Proportion Analysis by Market Taxonomy

        17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.8.2.1. By Route of Administration

            17.8.2.2. By Facility of Use

            17.8.2.3. By Application

    17.9. BENELUX Market Analysis

        17.9.1. Value Proportion Analysis by Market Taxonomy

        17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.9.2.1. By Route of Administration

            17.9.2.2. By Facility of Use

            17.9.2.3. By Application

    17.10. UK Market Analysis

        17.10.1. Value Proportion Analysis by Market Taxonomy

        17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.10.2.1. By Route of Administration

            17.10.2.2. By Facility of Use

            17.10.2.3. By Application

    17.11. Nordic Countries Market Analysis

        17.11.1. Value Proportion Analysis by Market Taxonomy

        17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.11.2.1. By Route of Administration

            17.11.2.2. By Facility of Use

            17.11.2.3. By Application

    17.12. China Market Analysis

        17.12.1. Value Proportion Analysis by Market Taxonomy

        17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.12.2.1. By Route of Administration

            17.12.2.2. By Facility of Use

            17.12.2.3. By Application

    17.13. Japan Market Analysis

        17.13.1. Value Proportion Analysis by Market Taxonomy

        17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.13.2.1. By Route of Administration

            17.13.2.2. By Facility of Use

            17.13.2.3. By Application

    17.14. South Korea Market Analysis

        17.14.1. Value Proportion Analysis by Market Taxonomy

        17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.14.2.1. By Route of Administration

            17.14.2.2. By Facility of Use

            17.14.2.3. By Application

    17.15. GCC Countries Market Analysis

        17.15.1. Value Proportion Analysis by Market Taxonomy

        17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.15.2.1. By Route of Administration

            17.15.2.2. By Facility of Use

            17.15.2.3. By Application

    17.16. South Africa Market Analysis

        17.16.1. Value Proportion Analysis by Market Taxonomy

        17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.16.2.1. By Route of Administration

            17.16.2.2. By Facility of Use

            17.16.2.3. By Application

    17.17. Turkey Market Analysis

        17.17.1. Value Proportion Analysis by Market Taxonomy

        17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.17.2.1. By Route of Administration

            17.17.2.2. By Facility of Use

            17.17.2.3. By Application

        17.17.3. Competition Landscape and Player Concentration in the Country

18. Market Structure Analysis

    18.1. Market Analysis by Tier of Companies 

    18.2. Market Concentration

    18.3. Market Share Analysis of Top Players

    18.4. Market Presence Analysis

        18.4.1. By Regional footprint of Players

        18.4.2. Product footprint by Players

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Competition Deep Dive 

        19.3.1. Johnson & Johnson

            19.3.1.1. Overview

            19.3.1.2. Product Portfolio

            19.3.1.3. Sales Footprint

            19.3.1.4. Strategy Overview

        19.3.2. Novartis International AG

            19.3.2.1. Overview

            19.3.2.2. Product Portfolio

            19.3.2.3. Sales Footprint

            19.3.2.4. Strategy Overview

        19.3.3. F. Hoffmann-La Roche AG

            19.3.3.1. Overview

            19.3.3.2. Product Portfolio

            19.3.3.3. Sales Footprint

            19.3.3.4. Strategy Overview

        19.3.4. Pfizer Inc

            19.3.4.1. Overview

            19.3.4.2. Product Portfolio

            19.3.4.3. Sales Footprint

            19.3.4.4. Strategy Overview

        19.3.5. Becton Dickinson & Company

            19.3.5.1. Overview

            19.3.5.2. Product Portfolio

            19.3.5.3. Sales Footprint

            19.3.5.4. Strategy Overview

        19.3.6. Glaxosmithkline PLC

            19.3.6.1. Overview

            19.3.6.2. Product Portfolio

            19.3.6.3. Sales Footprint

            19.3.6.4. Strategy Overview

        19.3.7. Merck & Co Inc

            19.3.7.1. Overview

            19.3.7.2. Product Portfolio

            19.3.7.3. Sales Footprint

            19.3.7.4. Strategy Overview

        19.3.8. Sanofi

            19.3.8.1. Overview

            19.3.8.2. Product Portfolio

            19.3.8.3. Sales Footprint

            19.3.8.4. Strategy Overview

        19.3.9. Bayer AG

            19.3.9.1. Overview

            19.3.9.2. Product Portfolio

            19.3.9.3. Sales Footprint

            19.3.9.4. Strategy Overview

        19.3.10. 3M

            19.3.10.1. Overview

            19.3.10.2. Product Portfolio

            19.3.10.3. Sales Footprint

            19.3.10.4. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Market Value (US$ Mn), By Route of Administration, 2015 – 2021

Table 2: Global Market Value (US$ Mn), By Route of Administration, 2022 – 2032

Table 3: Global Market Value (US$ Mn), By Facility of Use, 2015 – 2021

Table 4: Global Market Value (US$ Mn), By Facility of Use, 2022 – 2032

Table 5: Global Market Value (US$ Mn), By Application, 2015 – 2021

Table 6: Global Market Value (US$ Mn), By Application, 2022 – 2032

Table 7: Global Market, By Region, 2015 – 2021

Table 8: Global Market, By Region, 2022 – 2032

Table 9: North America Market Value (US$ Mn), By Route of Administration, 2015 – 2021

Table 10: North America Market Value (US$ Mn), By Route of Administration, 2022 – 2032

Table 11: North America Market Value (US$ Mn), By Facility of Use, 2015 – 2021

Table 12: North America Market Value (US$ Mn), By Facility of Use, 2022 – 2032

Table 13: North America Market Value (US$ Mn), By Application, 2015 – 2021

Table 14: North America Market Value (US$ Mn), By Application, 2022 – 2032

Table 15: North America Market, By Country, 2015 – 2021

Table 16: North America Market, By Country, 2022 – 2032

Table 17: Latin America Market Value (US$ Mn), By Route of Administration, 2015 – 2021

Table 18: Latin America Market Value (US$ Mn), By Route of Administration, 2022 – 2032

Table 19: Latin America Market Value (US$ Mn), By Facility of Use, 2015 – 2021

Table 20: Latin America Market Value (US$ Mn), By Facility of Use, 2022 – 2032

Table 21: Latin America Market Value (US$ Mn), By Application, 2015 – 2021

Table 22: Latin America Market Value (US$ Mn), By Application, 2022 – 2032

Table 23: Latin America Market, By Country, 2015 – 2021

Table 24: Latin America Market, By Country, 2022 – 2032

Table 25: Europe Market Value (US$ Mn), By Route of Administration, 2015 – 2021

Table 26: Europe Market Value (US$ Mn), By Route of Administration, 2022 – 2032

Table 27: Europe Market Value (US$ Mn), By Facility of Use, 2015 – 2021

Table 28: Europe Market Value (US$ Mn), By Facility of Use, 2022 – 2032

Table 29: Europe Market Value (US$ Mn), By Application, 2015 – 2021

Table 30: Europe Market Value (US$ Mn), By Application, 2022 – 2032

Table 31: Europe Market, By Country, 2015 – 2021

Table 32: Europe Market, By Country, 2022 – 2032

Table 33: Asia Pacific Market Value (US$ Mn), By Route of Administration, 2015 – 2021

Table 34: Asia Pacific Market Value (US$ Mn), By Route of Administration, 2022 – 2032

Table 35: Asia Pacific Market Value (US$ Mn), By Facility of Use, 2015 – 2021

Table 36: Asia Pacific Market Value (US$ Mn), By Facility of Use, 2022 – 2032

Table 37: Asia Pacific Market Value (US$ Mn), By Application, 2015 – 2021

Table 38: Asia Pacific Market Value (US$ Mn), By Application, 2022 – 2032

Table 39: Asia Pacific Market, By Country, 2015 – 2021

Table 40: Asia Pacific Market, By Country, 2022 – 2032

Table 41: MEA Market Value (US$ Mn), By Route of Administration, 2015 – 2021

Table 42: MEA Market Value (US$ Mn), By Route of Administration, 2022 – 2032

Table 43: MEA Market Value (US$ Mn), By Facility of Use, 2015 – 2021

Table 44: MEA Market Value (US$ Mn), By Facility of Use, 2022 – 2032

Table 45: MEA Market Value (US$ Mn), By Application, 2015 – 2021

Table 46: MEA Market Value (US$ Mn), By Application, 2022 – 2032

Table 47: MEA Market, By Country, 2015 – 2021

Table 48: MEA Market, By Country, 2022 – 2032

Table 49: Global Market Incremental $ Opportunity, By Route of Administration, 2015 - 2021

Table 50: Global Market Incremental $ Opportunity, By Facility of Use, 2022 – 2032

Table 51: Global Market Incremental $ Opportunity, By Application, 2015 - 2021

Table 52: Global Market Incremental $ Opportunity, By Region, 2022 – 2032

Table 53: North America Market Incremental $ Opportunity, By Route of Administration, 2015 - 2021

Table 54: North America Market Incremental $ Opportunity, By Facility of Use, 2022 – 2032

Table 55: North America Market Incremental $ Opportunity, By Application, 2015 – 2021

Table 56: North America Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 57: Latin America Market Incremental $ Opportunity, By Route of Administration, 2015 - 2021

Table 58: Latin America Market Incremental $ Opportunity, By Facility of Use, 2022 – 2032

Table 59: Latin America Market Incremental $ Opportunity, By Application, 2015 - 2021

Table 60: Latin America Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 61: Europe Market Incremental $ Opportunity, By Route of Administration, 2015 - 2021

Table 62: Europe Market Incremental $ Opportunity, By Facility of Use, 2022 – 2032

Table 63: Europe Market Incremental $ Opportunity, By Application, 2015 - 2021

Table 64: Europe Market Incremental $ Opportunity, By Country, 2022 - 2032

Table 65: Asia Pacific Market Incremental $ Opportunity, By Route of Administration, 2015 - 2021

Table 66: Asia Pacific Market Incremental $ Opportunity, By Facility of Use, 2022 – 2032

Table 67: Asia Pacific Market Incremental $ Opportunity, By Application, 2015 - 2021

Table 68: Asia Pacific Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 69: MEA Market Incremental $ Opportunity, By Route of Administration, 2015 - 2021

Table 70: MEA Market Incremental $ Opportunity, By Facility of Use, 2022 – 2032

Table 71: MEA Market Incremental $ Opportunity, By Application, 2015 - 2021

Table 72: MEA Market Incremental $ Opportunity, By Country, 2022 - 2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 2: Global Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global Market Share, By Route of Administration, 2022 & 2032

Figure 4: Global Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032

Figure 5: Global Market Attractiveness Index, By Route of Administration – 2022-2032

Figure 6: Global Market Share, By Facility of Use, 2022 & 2032

Figure 7: Global Market Y-o-Y Growth Projections, By Facility of Use – 2022-2032

Figure 8: Global Market Attractiveness Index, By Facility of Use – 2022-2032

Figure 9: Global Market Share, By Application, 2022 & 2032

Figure 10: Global Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 11: Global Market Attractiveness Index, By Application – 2022-2032

Figure 12: Global Market Share, By Region, 2022 & 2032

Figure 13: Global Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 14: Global Market Attractiveness Index, By Region – 2022-2032

Figure 15: North America Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 16: North America Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 17: North America Market Share, By Route of Administration, 2022 & 2032

Figure 18: North America Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032

Figure 19: North America Market Attractiveness Index, By Route of Administration – 2022-2032

Figure 20: North America Market Share, By Facility of Use, 2022 & 2032

Figure 21: North America Market Y-o-Y Growth Projections, By Facility of Use – 2022-2032

Figure 22: North America Market Attractiveness Index, By Facility of Use – 2022-2032

Figure 23: North America Market Share, By Application, 2022 & 2032

Figure 24: North America Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 25: North America Market Attractiveness Index, By Application – 2022-2032

Figure 26: North America Market Share, By Country, 2022 & 2032

Figure 27: North America Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 28: North America Market Attractiveness Index, By Country – 2022-2032

Figure 29: Latin America Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 30: Latin America Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 31: Latin America Market Share, By Route of Administration, 2022 & 2032

Figure 32: Latin America Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032

Figure 33: Latin America Market Attractiveness Index, By Route of Administration – 2022-2032

Figure 34: Latin America Market Share, By Facility of Use, 2022 & 2032

Figure 35: Latin America Market Y-o-Y Growth Projections, By Facility of Use – 2022-2032

Figure 36: Latin America Market Attractiveness Index, By Facility of Use – 2022-2032

Figure 37: Latin America Market Share, By Application, 2022 & 2032

Figure 38: Latin America Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 39: Latin America Market Attractiveness Index, By Application – 2022-2032

Figure 40: Latin America Market Share, By Country, 2022 & 2032

Figure 41: Latin America Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 42: Latin America Market Attractiveness Index, By Country – 2022-2032

Figure 43: Europe Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 44: Europe Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 45: Europe Market Share, By Route of Administration, 2022 & 2032

Figure 46: Europe Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032

Figure 47: Europe Market Attractiveness Index, By Route of Administration – 2022-2032

Figure 48: Europe Market Share, By Facility of Use, 2022 & 2032

Figure 49: Europe Market Y-o-Y Growth Projections, By Facility of Use – 2022-2032

Figure 50: Europe Market Attractiveness Index, By Facility of Use – 2022-2032

Figure 51: Europe Market Share, By Application, 2022 & 2032

Figure 52: Europe Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 53: Europe Market Attractiveness Index, By Application – 2022-2032

Figure 54: Europe Market Share, By Country, 2022 & 2032

Figure 55: Europe Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 56: Europe Market Attractiveness Index, By Country – 2022-2032

Figure 57: MEA Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 58: MEA Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 59: MEA Market Share, By Route of Administration, 2022 & 2032

Figure 60: MEA Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032

Figure 61: MEA Market Attractiveness Index, By Route of Administration – 2022-2032

Figure 62: MEA Market Share, By Facility of Use, 2022 & 2032

Figure 63: MEA Market Y-o-Y Growth Projections, By Facility of Use – 2022-2032

Figure 64: MEA Market Attractiveness Index, By Facility of Use – 2022-2032

Figure 65: MEA Market Share, By Application, 2022 & 2032

Figure 66: MEA Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 67: MEA Market Attractiveness Index, By Application – 2022-2032

Figure 68: MEA Market Share, By Country, 2022 & 2032

Figure 69: MEA Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 70: MEA Market Attractiveness Index, By Country – 2022-2032

Figure 71: Asia Pacific Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 72: Asia Pacific Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 73: Asia Pacific Market Share, By Route of Administration, 2022 & 2032

Figure 74: Asia Pacific Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032

Figure 75: Asia Pacific Market Attractiveness Index, By Route of Administration – 2022-2032

Figure 76: Asia Pacific Market Share, By Facility of Use, 2022 & 2032

Figure 77: Asia Pacific Market Y-o-Y Growth Projections, By Facility of Use – 2022-2032

Figure 78: Asia Pacific Market Attractiveness Index, By Facility of Use – 2022-2032

Figure 79: Asia Pacific Market Share, By Application, 2022 & 2032

Figure 80: Asia Pacific Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 81: Asia Pacific Market Attractiveness Index, By Application – 2022-2032

Figure 82: Asia Pacific Market Share, By Country, 2022 & 2032

Figure 83: Asia Pacific Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 84: Asia Pacific Market Attractiveness Index, By Country – 2022-2032

Figure 85: US Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 86: US Market Share, By Route of Administration, 2021

Figure 87: US Market Share, By Facility of Use, 2021

Figure 88: US Market Share, By Application, 2021

Figure 89: Canada Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 90: Canada Market Share, By Route of Administration, 2021

Figure 91: Canada Market Share, By Facility of Use, 2021

Figure 92: Canada Market Share, By Application, 2021

Figure 93: Brazil Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 94: Brazil Market Share, By Route of Administration, 2021

Figure 95: Brazil Market Share, By Facility of Use, 2021

Figure 96: Brazil Market Share, By Application, 2021

Figure 97: Mexico Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 98: Mexico Market Share, By Route of Administration, 2021

Figure 99: Mexico Market Share, By Facility of Use, 2021

Figure 100: Mexico Market Share, By Application, 2021

Figure 101: Germany Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 102: Germany Market Share, By Route of Administration, 2021

Figure 103: Germany Market Share, By Facility of Use, 2021

Figure 104: Germany Market Share, By Application, 2021

Figure 105: U.K. Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 106: U.K. Market Share, By Route of Administration, 2021

Figure 107: U.K. Market Share, By Facility of Use, 2021

Figure 108: U.K. Market Share, By Application, 2021

Figure 109: France Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 110: France Market Share, By Route of Administration, 2021

Figure 111: France Market Share, By Facility of Use, 2021

Figure 112: France Market Share, By Application, 2021

Figure 113: Italy Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 114: Italy Market Share, By Route of Administration, 2021

Figure 115: Italy Market Share, By Facility of Use, 2021

Figure 116: Italy Market Share, By Application, 2021

Figure 117: BENELUX Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 118: BENELUX Market Share, By Route of Administration, 2021

Figure 119: BENELUX Market Share, By Facility of Use, 2021

Figure 120: BENELUX Market Share, By Application, 2021

Figure 121: Nordic Countries Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 122: Nordic Countries Market Share, By Route of Administration, 2021

Figure 123: Nordic Countries Market Share, By Facility of Use, 2021

Figure 124: Nordic Countries Market Share, By Application, 2021

Figure 125: China Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 126: China Market Share, By Route of Administration, 2021

Figure 127: China Market Share, By Facility of Use, 2021

Figure 128: China Market Share, By Application, 2021

Figure 129: Japan Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 130: Japan Market Share, By Route of Administration, 2021

Figure 131: Japan Market Share, By Facility of Use, 2021

Figure 132: Japan Market Share, By Application, 2021

Figure 133: South Korea Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 134: South Korea Market Share, By Route of Administration, 2021

Figure 135: South Korea Market Share, By Facility of Use, 2021

Figure 136: South Korea Market Share, By Application, 2021

Figure 137: GCC Countries Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 138: GCC Countries Market Share, By Route of Administration, 2021

Figure 139: GCC Countries Market Share, By Facility of Use, 2021

Figure 140: GCC Countries Market Share, By Application, 2021

Figure 141: South Africa Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 142: South Africa Market Share, By Route of Administration, 2021

Figure 143: South Africa Market Share, By Facility of Use, 2021

Figure 144: South Africa Market Share, By Application, 2021

Figure 145: Turkey Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 146: Turkey Market Share, By Route of Administration, 2021

Figure 147: Turkey Market Share, By Facility of Use, 2021

Figure 148: Turkey Market Share, By Application, 2021

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Injectable Drugs Market

Published : June 2022

Healthcare

Injectable Benzodiazepine Market

Published : June 2020

Healthcare

Microneedle Drug Delivery Systems Market

Published : November 2020

Healthcare

Injectable Drug Delivery Market

Published : December 2021

Google translate

Pharmaceutical Drug Delivery Market